Abstract
Anaplastic lymphoma kinase (ALK) is a particularly promising target for the development of small molecule anti-cancer drugs. In the present study, comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) were performed on 60 ALK inhibitors to build three-dimensional quantitative structure–activity relationship models. Both the ligand-based resultants of CoMFA (r 2 0.970, q 2 0.660) and CoMSIA (r 2 0.979, q 2 0.623) models exhibited good predictability. The resulting contour maps illustrated the regions where interactive fields may affect the activity. Molecular docking was then performed to explore the interactions between these inhibitors and the ALK-4DCE protein. A few key residues (His32, Gly31, Gly169, Asp170, Val35, Ala100, Pro160, Lys50, and Leu30) at the binding site of 4DCE were identified. Molecular dynamics simulation further verified the reliability. The information acquired in this work not only provides a better appreciation of interactions between these molecules and the ALK receptor but could also be applied to design more effective ALK inhibitors.
Graphical abstract
Similar content being viewed by others
References
Achary R, Yun JI, Park CM (2016) Bioorg Med Chem 24:207
Le Beau MM, Bitter MA, Larson RA (1989) Leukemia 3:866
Gleason BC, Hornick JL (2008) J Clin Pathol 61:428
Lee HW, Kim K, Kim W, Ko YH (2008) Hematol Oncol 26:108
Debelenko LV, Raimondi SC, Daw N (2011) Mod Pathol 24:430
Soda M, Choi YL, Enomoto M (2007) Nature 448:561
Caren H, Abel F, Kogner P, Martinsson T (2008) Biochem J 416:153
Mosse YP, Laudenslager M, Longo L (2008) Nature 455:930
Ren H, Tan ZP, Zhu X (2012) Cancer Res 72:3312
Katayama R, Friboulet L, Koike S (2014) Clin Cancer Res 20:5686
Choudhari R, Minero VG, Menotti M (2016) Blood 127:1297
Moritake H, Shimonodan H, Marutsuka K (2011) Am J Hematol 86:75
Wynne C, Lazzari E, Smith S (2014) PLoS One 9:e101503
Tort F, Pinyol M, Pulford K (2001) Lab Invest 81:419
Vyas VK, Patel A, Gupta N, Ghate M (2014) Med Chem Res 23:603
Liu ZQ, Yue XH, Song ZL (2014) Eur J Med Chem 86:438
Marsilje TH, Pei W, Chen B (2013) J Med Chem 56:5675
Christensen JG, Zou HY, Arango ME (2007) Mol Cancer Ther 6:3314
Kinoshita K, Asoh K, Furuichi N (2012) Bioorg Med Chem 20:1271
Katayama R, Khan TM, Benes C (2011) Proc Natl Acad Sci USA 108:7535
Galkin AV, Melnick JS, Kim S (2007) Proc Natl Acad Sci USA 104:270
Lovly CM, Heuckmann JM, Thomas RK (2011) Cancer Res 71:4920
Ke ZP, Lu T, Liu HC (2014) J Mol Struct 1067:127
Song ZL, Yang YH, Liu ZQ (2015) J Med Chem 58:197
Cheng LP, Huang XY, Wang Z, Kai ZP, Wu FH (2014) Monatsh Chem 145:1213
Wang P, Cai J, Chen JQ (2014) Med Chem Res 23:2576
Lv QQ, Wang ZH, Wang ZH, Wu FH (2015) Lett Drug Des Discov 12:219
Liu ZQ, Ai J, Peng X, Song ZL (2014) ACS Med Chem Lett 5:304
Boehm M, Stuerzebecher J, Klebe G (1999) J Med Chem 42:458
Liu J, Li Y, Zhang HX, Zhang SW (2012) J Mol Model 18:991
Clark M, Cramer RD III, Van ON (1989) J Comput Chem 10:982
Wang FF, Yang W, Shi YH, Le GW (2015) J Biomol Struct Dyn 33:1929
Thaimattam R, Daga PR, Banerjee R, Iqbal J (2005) Bioorg Med Chem 13:4704
Liu JL, Wang FF, Ma Z, Wang X (2011) Int J Mol Sci 12:946
Xu C, Ren YJ (2015) Bioorg Med Chem Lett 25:4522
Kirkpatrick P (2004) Nat Rev Drug Discov 3:299
Acknowledgements
We are grateful for financial support from the National Natural Science Foundation of China (21172148, 21472126, and 21502117) and Shanghai Municipal Education Commission (Plateau Discipline Construction Program).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Li, DD., Wu, FL., Wang, ZH. et al. Identification of 2,4-diarylaminopyrimidine analogues as ALK inhibitors by using 3D-QSAR, molecular docking, and molecular dynamics simulations. Monatsh Chem 148, 1711–1725 (2017). https://doi.org/10.1007/s00706-017-1999-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-017-1999-4